Dow Up 0.25% Nasdaq Up 0.65%

More On GRFS

Grifols, S.A. (GRFS)

-NasdaqGS
16.10 Up 0.13(0.81%) May 27, 4:00PM EDT
Prev Close:15.97
Open:15.99
Bid:N/A
Ask:17.00 x 6900
1y Target Est:16.50
Beta:0.999482
Next Earnings Date:N/A
Day's Range:15.87 - 16.16
52wk Range:14.07 - 18.04
Volume:1,526,105
Avg Vol (3m):1,447,590
Market Cap:22.01B
P/E (ttm):37.44
EPS (ttm):0.43
Div & Yield:0.38 (2.39%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):14.00
P/S (ttm):4.88
Ex-Dividend Date:10-Dec-15

Analysts

Annual EPS Est (Dec-16) :1.04
Quarterly EPS Est (Jun-16) :0.27
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):1.03

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Grifols, S.A., a biopharmaceutical company, develops, manufactures, and distributes plasma derivative products in the United States, Canada, Spain, rest of the European Union, and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback